TP53 and cervical carcinoma: The molecular etiology of HPV-negative ADC is not yet clear, but some studies suggest that mutations in TP53, PIK3CA, and CDKN2A may be associated with its pathogenesis.[9–12] For HPV-negative cervical cancer, there is currently no specific treatment available.